The Role of m6A Modification in Regulating MSC Differentiation and Immunomodulation: Implications for Regenerative Medicine and Therapeutic Applications
Open Access
- 24 September 2025
- journal article
- review article
- Published by IMR Press in Frontiers in Bioscience-Landmark
- Vol. 30 (9) , 36475
Abstract
Mesenchymal stem cells (MSCs) are widely utilized in tissue repair, anti-inflammatory treatment, and cell therapy due to their remarkable multidirectional differentiation potential, immunosuppressive capabilities, and low immunogenicity. However, the regulatory mechanisms underlying their functions are intricate, and epigenetic modifications are a significant contributing factor. N6-methyladenosine (m6A) modification affects the proliferation, differentiation, and immunomodulation of MSCs by regulating the stability, transport, and translation of RNA. Studies have shown that m6A modification promotes osteogenic differentiation through the bone morphogehetic protein/small mothers against decapentaplegic (BMP/Smad) and wingless-related integration site/β-catenin (Wnt/β-catenin) pathways. It also enhances the anti-inflammatory effect of MSCs by modulating immune cell polarization and the release of inflammatory mediators. Moreover, exosomes secreted by MSCs contribute to immunomodulation and the response to cancer treatment by regulating the m6A modification of genes in target cells. “Writers” of m6A, such as methyltransferase-like 3 (METTL3) and METTL14, and “erasers”, such as fat mass and obesity-associated protein (FTO) and alkB homolog 5 (ALKBH5), are crucial in regulating the functions of MSCs. Targeting m6A modification via the clinical application of MSCs may represent a new cancer treatment strategy. Therefore, a comprehensive investigation of the m6A regulatory mechanism is essential. This review provides theoretical and technical support for the clinical use of MSCs, facilitating the development of more effective therapeutic strategies.Keywords
This publication has 142 references indexed in Scilit:
- Quercetin‐Loaded Bioglass Injectable Hydrogel Promotes m6A Alteration of Per1 to Alleviate Oxidative Stress for Periodontal Bone DefectsAdvanced Science, 2024
- IGF2BP3-mediated enhanced stability of MYLK represses MSC adipogenesis and alleviates obesity and insulin resistance in HFD miceCellular and Molecular Life Sciences, 2024
- Immunomodulatory functions of oral mesenchymal stem cells: Novel force for tissue regeneration and disease therapyJournal of Leukocyte Biology, 2021
- METTL3 mediates bone marrow mesenchymal stem cell adipogenesis to promote chemoresistance in acute myeloid leukaemiaFEBS Open Bio, 2021
- Human mesenchymal stromal cells and derived extracellular vesicles: Translational strategies to increase their proangiogenic potential for the treatment of cardiovascular diseaseStem Cells Translational Medicine, 2020
- Mesenchymal Stem Cells in the Tumor Microenvironment2020
- Role of bone marrow adipocytes in leukemia and chemotherapy challengesCellular and Molecular Life Sciences, 2019
- Mesenchymal stem cells in the aseptic loosening of total joint replacementsJournal of Biomedical Materials Research Part A, 2016
- microRNA‐21 promotes osteogenic differentiation of mesenchymal stem cells by the PI3K/β‐catenin pathwayJournal of Orthopaedic Research, 2015
- Spatiotemporal Analyses of Osteogenesis and Angiogenesis via Intravital Imaging in Cranial Bone Defect RepairJournal of Bone and Mineral Research, 2015